Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin

被引：0
|
作者：
Martin, Silas C.
Henk, Henry J.
Chow, Wing
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1181-P
引用
收藏
页码：A307 / A307
页数：1
相关论文
共 50 条
  • [21] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [22] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    [J]. FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [23] Characteristics of a large urban pediatric population with type 2 diabetes mellitus (T2DM)
    Katz, LEL
    Norris, R
    Weinzimer, SA
    Jawad, AF
    Preis, CM
    McKnight, H
    Murphy, KM
    [J]. DIABETES, 2001, 50 : A380 - A380
  • [24] HOW DIFFERENT WERE THEY? A TREATMENT PATTERN ANALYSIS OF UNITED STATES PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INITIATING INJECTABLE THERAPY
    Walker, V
    Wei, W.
    Thayer, S.
    Brekke, L.
    Crown, W.
    Grabner, M.
    Raparla, S.
    Quimbo, R.
    Cziraky, M.
    Hu, W.
    Cuddihy, R.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A493 - A493
  • [25] IS CANAGLIFLOZIN COST-EFFECTIVE COMPARED TO SITAGLIPTIN ACROSS MULTIPLE LINES OF TYPE 2 DIABETES MELLITUS (T2DM) THERAPY IN IRELAND?
    Bacon, T.
    Willis, M.
    Johansen, P.
    Neslusan, C.
    Nuhoho, S.
    Worbes-Cerezo, M.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A345 - A345
  • [26] Characteristics of people with type 2 diabetes mellitus initiating canagliflozin in the real world
    不详
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2014, 20 : 17 - 19
  • [27] Real-World Outcomes of Patients with Type 2 Diabetes Mellitus (T2DM) Treated with Canagliflozin in a US Managed Care Setting
    Chow, Wing
    Buysman, Erin K.
    Rupnow, Marcia F. T.
    Henk, Henry J.
    [J]. DIABETES, 2015, 64 : A347 - A348
  • [28] Effect of Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM) Who Were, or Were Not, on Antihyperglycemic Agents (AHAs) at Screening
    Gonzalez-Galvez, Guillermo
    Kim, Kyoung-Ah
    Jodar, Esteban
    Alba, Maria
    Tong, Cindy
    Meininger, Gary
    [J]. DIABETES, 2014, 63 : A280 - A280
  • [29] Efficacy and Safety of Canagliflozin (CANA) Monotherapy in Subjects With Type 2 Diabetes Mellitus (T2DM) Over 52 Weeks
    Stenloef, Kaj
    Cefalu, William T.
    Kim, Kyoung-Ah
    Jodar, Esteban
    Alba, Maria
    Edwards, Robert
    Tong, Cindy
    Canovatchel, William
    Meininger, Gary
    [J]. DIABETES, 2013, 62 : A303 - A303
  • [30] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
    Kosmalski, M.
    Drozdowska, A.
    Sliwinska, A.
    Drzewoski, J.
    [J]. ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
12345